Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 652

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 652
---
| ARTICLE XII. FINANCING               |                                                                                                            |     | 84 |
| 12.1                                 | Financing.                                                                                                 |     | 84 |
| ARTICLE XIII. DEFINITIONS            |                                                                                                            |     | 84 |
| 13.1                                 | Certain Definitions.                                                                                       |     | 84 |

| iii |

INDEX OF EXHIBITS

| Exhibit |     | Description                                     |
| Exhibit 
 A       |     | Cerevast                                        
 Contribution and Exchange Agreement, as amended |
| Exhibit 
 B       |     | Aegeria                                         
 Contribution and Exchange Agreement, as amended |
| Exhibit 
 C       |     | Form                                            
 of Longevity Support Agreement                  |
| Exhibit 
 D       |     | Form                                            
 of FutureTech II Support Agreement              |

| iv |

<div align='center'>AGREEMENT AND PLAN OF MERGER</div>

THIS AGREEMENT AND PLAN OF MERGER (this “ Agreement”) is made and entered into as of September 16, 2024 by and among:

| A. | FutureTech                                                                       
 II Acquisition Corp., a Delaware corporation (the “Purchaser”);                  |
| B. | Longevity                                                                        
 Biomedical, Inc. (the “Company”), a Delaware corporation;                        |
| C. | LBI                                                                              
 Merger Sub, Inc. (“Merger Sub”), a Delaware corporation; and                     |
| D. | Bradford                                                                         
 A. Zakes, solely in the capacity as Seller Representative hereunder (the “Seller 
 Representative”).                                                                |

Purchaser, the Company, Merger Sub and the Seller Representative are sometimes referred to herein individually as a “ Party” and, collectively, as the “ Parties”. Capitalized terms used and not otherwise defined herein have the meaning set forth in Article XIII.

<div align='center'>RECITALS:</div>

WHEREAS, Purchaser is a blank check company incorporated in Delaware and formed for the sole purpose of entering into a Business Combination with one or more businesses or entities;

WHEREAS, Merger Sub is a newly formed, wholly-owned, direct Subsidiary of the Purchaser, and was formed for the sole purpose of consummating the transactions contemplated by this Agreement, including the Merger;

WHEREAS, on August 7, 2022, the Company entered into that certain Contribution and Exchange Agreement, attached hereto as Exhibit A(as supplemented and amended to date, the “ Cerevast Acquisition Agreement”), with Cerevast Medical